{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:52:15Z","timestamp":1776750735839,"version":"3.51.2"},"posted":{"date-parts":[[2026,1,16]]},"group-title":"Pharmacology and Toxicology","reference-count":99,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["R00MH126098"],"award-info":[{"award-number":["R00MH126098"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BBRF Foundation","award":["29063"],"award-info":[{"award-number":["29063"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,16]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Chronic stress disrupts glutamatergic and GABAergic plasticity in the medial prefrontal cortex (mPFC), impairing circuit integration and contributing to the pathophysiology of stress-related disorders, such as Major Depressive Disorder (MDD). Rapid-acting antidepressants like ketamine can rapidly reverse these deficits, but its clinical use is limited by psychotomimetic side effects. Notably, the \u03b15-GABA\n                  <jats:sub>A<\/jats:sub>\n                  R negative allosteric modulator (\u03b15-NAM) Basmisanil (BSM), reproduces ketamine-like behavioral outcomes in preclinical models, although the cellular mechanisms underlying its actions remain unclear. Here, we investigated whether BSM promotes ketamine-like enhancement of cortical plasticity and engages cell type-specific mechanisms to support adaptive behaviors over time. We show that BSM produced rapid and sustained facilitation of motivational, hedonic, and active coping behaviors via mPFC circuits. BSM induced c-Fos expression in mPFC D1R- and somatostatin-expressing cells, suggesting activation of specific subsets of pyramidal and GABA interneurons. In both mPFC and hippocampus, BSM rapidly activated Erk- or Akt-mTOR signaling pathways as well as increased synaptic proteins critical for glutamatergic and GABAergic function. BSM also reversed maladaptive behaviors induced by chronic unpredictable stress, including impairment in object recognition memory and social interaction. Finally, chemogenetic silencing of mPFC CaMKII-expressing neurons blocked both rapid and sustained actions of BSM, whereas inhibition of mPFC GABA interneurons reversed only long-term behavioral outcomes. These results indicate that \u03b15-GABA\n                  <jats:sub>A<\/jats:sub>\n                  R modulation requires early activation of pyramidal neurons to drive rapid plasticity, while GABAergic adaptations support sustained improvements. This dynamic mechanism restores excitation\u2013inhibition (E\/I) balance and highlights GABAergic pathways as therapeutic targets for prefrontal dysfunction in stress disorders.\n                <\/jats:p>","DOI":"10.64898\/2026.01.15.699507","type":"posted-content","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:15:13Z","timestamp":1768572913000},"source":"Crossref","is-referenced-by-count":0,"title":["Negative allosteric modulation of \u03b15-GABA\n                  <sub>A<\/sub>\n                  receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice"],"prefix":"10.64898","author":[{"given":"Fernanda","family":"Daher","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caio T.","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik A.","family":"Ingebretsen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Bidlack","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Atack","sequence":"additional","affiliation":[{"name":"Medicines Discovery Institute, Cardiff University, Park Place, CF10 3AT, Cardiff, Wales, United Kingdom"},{"name":"Draig Therapeutics, Sbarc Building, Maindy Road, Cardiff, CF24 4HQ, Cardiff, Wales, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana O.","family":"Popa","sequence":"additional","affiliation":[{"name":"Medicines Discovery Institute, Cardiff University, Park Place, CF10 3AT, Cardiff, Wales, United Kingdom"},{"name":"Draig Therapeutics, Sbarc Building, Maindy Road, Cardiff, CF24 4HQ, Cardiff, Wales, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4212-7424","authenticated-orcid":false,"given":"Manoela V.","family":"Foga\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, United States of America"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026020606451901000_2026.01.15.699507v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00757-8"},{"issue":"2","key":"2026020606451901000_2026.01.15.699507v1.2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD Mental Disorders C","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2026020606451901000_2026.01.15.699507v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.02.023"},{"key":"2026020606451901000_2026.01.15.699507v1.4","doi-asserted-by":"publisher","DOI":"10.1177\/0706743719828965"},{"issue":"2","key":"2026020606451901000_2026.01.15.699507v1.5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/d41573-025-00001-5","article-title":"2024 FDA approvals","volume":"24","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"2026020606451901000_2026.01.15.699507v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.5756"},{"key":"2026020606451901000_2026.01.15.699507v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0136-3"},{"issue":"6","key":"2026020606451901000_2026.01.15.699507v1.8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine Treatment and Global Brain Connectivity in Major Depression","volume":"42","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2026020606451901000_2026.01.15.699507v1.9","doi-asserted-by":"crossref","first-page":"111432","DOI":"10.1016\/j.pscychresns.2021.111432","article-title":"Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: A pilot study","volume":"320","year":"2022","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2026020606451901000_2026.01.15.699507v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.02.005"},{"key":"2026020606451901000_2026.01.15.699507v1.11","doi-asserted-by":"crossref","unstructured":"Gerhard DM , Pothula S , Liu RJ , Wu M , Li XY , Girgenti MJ , et al. GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J Clin Invest 2019.","DOI":"10.1172\/JCI130808"},{"key":"2026020606451901000_2026.01.15.699507v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/nature10130"},{"issue":"4","key":"2026020606451901000_2026.01.15.699507v1.13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41386-024-02002-1","article-title":"Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses","volume":"50","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"2026020606451901000_2026.01.15.699507v1.14","doi-asserted-by":"crossref","unstructured":"Ghosal S , Duman CH , Liu RJ , Wu M , Terwilliger R , Girgenti MJ , et al. Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents. Neurobiol Dis 2019:104669.","DOI":"10.1016\/j.nbd.2019.104669"},{"key":"2026020606451901000_2026.01.15.699507v1.15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856"},{"issue":"5","key":"2026020606451901000_2026.01.15.699507v1.16","doi-asserted-by":"crossref","first-page":"e204693","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis","volume":"3","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026020606451901000_2026.01.15.699507v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.04.035"},{"key":"2026020606451901000_2026.01.15.699507v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.120"},{"key":"2026020606451901000_2026.01.15.699507v1.19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions","volume":"13","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"2026020606451901000_2026.01.15.699507v1.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.142288699"},{"key":"2026020606451901000_2026.01.15.699507v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/cne.903590111"},{"key":"2026020606451901000_2026.01.15.699507v1.22","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X16661339"},{"key":"2026020606451901000_2026.01.15.699507v1.23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fnmol.2019.00179","article-title":"Neurobiology and Therapeutic Potential of alpha5-GABA Type A Receptors","volume":"12","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"2026020606451901000_2026.01.15.699507v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.06.009"},{"key":"2026020606451901000_2026.01.15.699507v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-023-01133-1"},{"issue":"6723","key":"2026020606451901000_2026.01.15.699507v1.26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.adt8990","article-title":"Gatekeepers of the brain: Identifying hidden mechanisms of type A GABA receptor signaling and assembly","volume":"386","year":"2024","journal-title":"Science"},{"key":"2026020606451901000_2026.01.15.699507v1.27","doi-asserted-by":"crossref","first-page":"137828","DOI":"10.1016\/j.neulet.2024.137828","article-title":"Basmisanil, an alpha5-GABA(A)R negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male mice","volume":"833","year":"2024","journal-title":"Neurosci Lett"},{"issue":"3","key":"2026020606451901000_2026.01.15.699507v1.28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2021.11.024","article-title":"Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at alpha5 Subunit-Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice","volume":"92","year":"2022","journal-title":"Biol Psychiatry"},{"key":"2026020606451901000_2026.01.15.699507v1.29","first-page":"446","article-title":"Sex-Dependent Anti-Stress Effect of an alpha5 Subunit Containing GABAA Receptor Positive Allosteric Modulator","volume":"7","year":"2016","journal-title":"Front Pharmacol"},{"key":"2026020606451901000_2026.01.15.699507v1.30","doi-asserted-by":"crossref","first-page":"24705470211020446","DOI":"10.1177\/24705470211020446","article-title":"Emerging Therapeutics Based on the Amino Acid Neurotransmitter System: An Update on the Pharmaceutical Pipeline for Mood Disorders","volume":"5","year":"2021","journal-title":"Chronic Stress (Thousand Oaks"},{"key":"2026020606451901000_2026.01.15.699507v1.31","doi-asserted-by":"crossref","unstructured":"Zanos P , Nelson ME , Highland JN , Krimmel SR , Georgiou P , Gould TD , et al. A Negative Allosteric Modulator for alpha5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice. eNeuro 2017;4(1).","DOI":"10.1523\/ENEURO.0285-16.2017"},{"key":"2026020606451901000_2026.01.15.699507v1.32","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.157636"},{"issue":"11","key":"2026020606451901000_2026.01.15.699507v1.33","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors","volume":"40","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"2026020606451901000_2026.01.15.699507v1.34","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01312"},{"key":"2026020606451901000_2026.01.15.699507v1.35","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-022-09418-0"},{"key":"2026020606451901000_2026.01.15.699507v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87307-7"},{"key":"2026020606451901000_2026.01.15.699507v1.37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85033"},{"key":"2026020606451901000_2026.01.15.699507v1.38","doi-asserted-by":"crossref","unstructured":"Moda-Sava RN , Murdock MH , Parekh PK , Fetcho RN , Huang BS , Huynh TN , et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 2019;364(6436).","DOI":"10.1126\/science.aat8078"},{"key":"2026020606451901000_2026.01.15.699507v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-020-00916-Y"},{"key":"2026020606451901000_2026.01.15.699507v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41088-2"},{"key":"2026020606451901000_2026.01.15.699507v1.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22116-z"},{"key":"2026020606451901000_2026.01.15.699507v1.42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: History, evaluation and usage","volume":"6","year":"2017","journal-title":"Neurobiol Stress"},{"key":"2026020606451901000_2026.01.15.699507v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.12.015"},{"key":"2026020606451901000_2026.01.15.699507v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01583-7"},{"key":"2026020606451901000_2026.01.15.699507v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.06.034"},{"key":"2026020606451901000_2026.01.15.699507v1.46","doi-asserted-by":"crossref","unstructured":"Gould TD , Dao, D.T. , Kovacsics, C.E. The Open Field Test. Mood and Anxiety Related Phenotypes in Mice. Neuromethods. 42. Totowa, NJ: Humana Press; 2009.","DOI":"10.1007\/978-1-60761-303-9"},{"key":"2026020606451901000_2026.01.15.699507v1.47","doi-asserted-by":"crossref","unstructured":"Fogaca MV , Daher F , Picciotto MR . Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses. Neuropsychopharmacology 2024.","DOI":"10.1101\/2024.07.29.605610"},{"key":"2026020606451901000_2026.01.15.699507v1.48","doi-asserted-by":"publisher","DOI":"10.3791\/3769"},{"issue":"6","key":"2026020606451901000_2026.01.15.699507v1.49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ijnp\/pyab002","article-title":"Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation","volume":"24","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026020606451901000_2026.01.15.699507v1.50","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241254832"},{"issue":"5","key":"2026020606451901000_2026.01.15.699507v1.51","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41380-024-02419-6","article-title":"(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice","volume":"29","year":"2024","journal-title":"Mol Psychiatry"},{"key":"2026020606451901000_2026.01.15.699507v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.05.007"},{"key":"2026020606451901000_2026.01.15.699507v1.53","doi-asserted-by":"crossref","unstructured":"Dorval L , Knapp BI , Majekodunmi OA , Eliseeva S , Bidlack JM . Mice with high FGF21 serum levels had a reduced preference for morphine and an attenuated development of acute antinociceptive tolerance and physical dependence. Neuropharmacology 2021:108858.","DOI":"10.1101\/2021.07.30.453845"},{"issue":"2","key":"2026020606451901000_2026.01.15.699507v1.54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/FBP.0b013e32835f3d2f","article-title":"Inhibition of Gbetagamma-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward","volume":"24","year":"2013","journal-title":"Behav Pharmacol"},{"key":"2026020606451901000_2026.01.15.699507v1.55","doi-asserted-by":"crossref","first-page":"603232","DOI":"10.3389\/fnbeh.2020.603232","article-title":"Oxytocin Attenuates Expression, but Not Acquisition, of Sucrose Conditioned Place Preference in Rats","volume":"14","year":"2020","journal-title":"Front Behav Neurosci"},{"key":"2026020606451901000_2026.01.15.699507v1.56","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190287"},{"key":"2026020606451901000_2026.01.15.699507v1.57","doi-asserted-by":"crossref","unstructured":"Fogaca MV , Fukumoto K , Franklin T , Liu RJ , Duman CH , Vitolo OV , et al. N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects. Neuropsychopharmacology 2019.","DOI":"10.1038\/s41386-019-0501-x"},{"key":"2026020606451901000_2026.01.15.699507v1.58","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14683"},{"key":"2026020606451901000_2026.01.15.699507v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.03.013"},{"key":"2026020606451901000_2026.01.15.699507v1.60","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01093-2"},{"key":"2026020606451901000_2026.01.15.699507v1.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04993-7"},{"key":"2026020606451901000_2026.01.15.699507v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00639-1"},{"key":"2026020606451901000_2026.01.15.699507v1.63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414728112"},{"key":"2026020606451901000_2026.01.15.699507v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.176"},{"key":"2026020606451901000_2026.01.15.699507v1.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.07.027"},{"key":"2026020606451901000_2026.01.15.699507v1.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.09.023"},{"key":"2026020606451901000_2026.01.15.699507v1.67","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhy299"},{"key":"2026020606451901000_2026.01.15.699507v1.68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08168-9"},{"key":"2026020606451901000_2026.01.15.699507v1.69","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14630"},{"key":"2026020606451901000_2026.01.15.699507v1.70","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1283-12.2012"},{"key":"2026020606451901000_2026.01.15.699507v1.71","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01625-0"},{"key":"2026020606451901000_2026.01.15.699507v1.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02141-3"},{"key":"2026020606451901000_2026.01.15.699507v1.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.025"},{"key":"2026020606451901000_2026.01.15.699507v1.74","doi-asserted-by":"publisher","DOI":"10.1159\/000495840"},{"key":"2026020606451901000_2026.01.15.699507v1.75","doi-asserted-by":"crossref","unstructured":"Li H , Zhao Z , Jiang S , Wu H . Brain circuits that regulate social behavior. Mol Psychiatry 2025.","DOI":"10.1038\/s41380-025-03037-6"},{"key":"2026020606451901000_2026.01.15.699507v1.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.06.030"},{"key":"2026020606451901000_2026.01.15.699507v1.77","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1205199"},{"key":"2026020606451901000_2026.01.15.699507v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.021"},{"key":"2026020606451901000_2026.01.15.699507v1.79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.apha.2020.03.002","article-title":"Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition","volume":"89","year":"2020","journal-title":"Adv Pharmacol"},{"key":"2026020606451901000_2026.01.15.699507v1.80","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2213-07.2007"},{"key":"2026020606451901000_2026.01.15.699507v1.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.1"},{"key":"2026020606451901000_2026.01.15.699507v1.82","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3446"},{"key":"2026020606451901000_2026.01.15.699507v1.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.058"},{"issue":"6","key":"2026020606451901000_2026.01.15.699507v1.84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.biopsych.2019.01.011","article-title":"Parsing the Hippocampus in Depression: Chronic Stress, Hippocampal Volume, and Major Depressive Disorder","volume":"85","year":"2019","journal-title":"Biol Psychiatry"},{"key":"2026020606451901000_2026.01.15.699507v1.85","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-024-00876-0"},{"key":"2026020606451901000_2026.01.15.699507v1.86","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01629-w"},{"issue":"10","key":"2026020606451901000_2026.01.15.699507v1.87","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/mp.2017.220","article-title":"BDNF release and signaling are required for the antidepressant actions of GLYX-13","volume":"23","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2026020606451901000_2026.01.15.699507v1.88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814709116"},{"key":"2026020606451901000_2026.01.15.699507v1.89","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb6748"},{"key":"2026020606451901000_2026.01.15.699507v1.90","doi-asserted-by":"publisher","DOI":"10.1002\/dneu.22280"},{"key":"2026020606451901000_2026.01.15.699507v1.91","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(02)02017-5"},{"key":"2026020606451901000_2026.01.15.699507v1.92","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0b013e3280117733"},{"key":"2026020606451901000_2026.01.15.699507v1.93","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706679105"},{"key":"2026020606451901000_2026.01.15.699507v1.94","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhi104"},{"key":"2026020606451901000_2026.01.15.699507v1.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.03.001"},{"key":"2026020606451901000_2026.01.15.699507v1.96","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001207"},{"key":"2026020606451901000_2026.01.15.699507v1.97","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002"},{"key":"2026020606451901000_2026.01.15.699507v1.98","doi-asserted-by":"publisher","DOI":"10.1038\/srep38771"},{"issue":"7","key":"2026020606451901000_2026.01.15.699507v1.99","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ijnp\/pyz025","article-title":"Cognitive Impairment That Is Induced by (R)-Ketamine Is Abolished in NMDA GluN2D Receptor Subunit Knockout Mice","volume":"22","year":"2019","journal-title":"Int J Neuropsychopharmacol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.01.15.699507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:45:33Z","timestamp":1770389133000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.01.15.699507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":99,"URL":"https:\/\/doi.org\/10.64898\/2026.01.15.699507","relation":{},"subject":[],"published":{"date-parts":[[2026,1,16]]},"subtype":"preprint"}}